Article Versions Notes

Zhang J, Zhang Y, Lei Y, Zheng Q, Gu X, Liu Z, Xu Y, Zhong C, Shan S, Ren T. Elevated Serum Direct Bilirubin and Smoking Status Are Prognostic Factors for EGFR-Mutated Non-Small Cell Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy. Cancers. 2024; 16(23):3982. https://doi.org/10.3390/cancers16233982

Zhang, Jingyuan, Yinwang Zhang, Yuqiong Lei, Qi Zheng, Xiaohua Gu, Zeyu Liu, Yongle Xu, Cheng Zhong, Shan Shan, and Tao Ren. 2024. "Elevated Serum Direct Bilirubin and Smoking Status Are Prognostic Factors for EGFR-Mutated Non-Small Cell Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy" Cancers 16, no. 23: 3982. https://doi.org/10.3390/cancers16233982

Zhang, J., Zhang, Y., Lei, Y., Zheng, Q., Gu, X., Liu, Z., Xu, Y., Zhong, C., Shan, S., & Ren, T. (2024). Elevated Serum Direct Bilirubin and Smoking Status Are Prognostic Factors for EGFR-Mutated Non-Small Cell Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy. Cancers, 16(23), 3982. https://doi.org/10.3390/cancers16233982